The Annals Take our Readership Survey!
home help contact us subscription past issues search current issue
 QUICK SEARCH:   [advanced]


     



Published Online, 25 April 2006, www.theannals.com, DOI 10.1345/aph.1G485.
The Annals of Pharmacotherapy: Vol. 40, No. 5, pp. 917-924. DOI 10.1345/aph.1G485
© 2006 Harvey Whitney Books Company.
This Article
Right arrow Résumé Freely available
Right arrow Extracto Freely available
Right arrow Full Text
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fassett, W. E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fassett, W. E

LAW

Patient Safety and Quality Improvement Act of 2005

William E Fassett, PhD

Professor of Pharmacy Law & Ethics, Department of Pharmacotherapy, College of Pharmacy, Washington State University—Spokane, PO Box 1495, Spokane, WA 99210-1495, fax 509/358-7744, fassett{at}wsu.edu

Reprints: Dr. Fassett

OBJECTIVE: To review Public Law (PL) 109-41—the Patient Safety and Quality Improvement Act of 2005 (PSQIA)—and summarize key medication error research that contributed to congressional recognition of the need for this legislation.

DATA SOURCES: Relevant publications related to medication error research, patient safety programs, and the legislative history of and commentary on PL 109-41, published in English, were identified by MEDLINE, PREMEDLINE, Thomas (Library of Congress), and Internet search engine-assisted searches using the terms healthcare quality, medication error, patient safety, PL 109-41, and quality improvement. Additional citations were identified from references cited in related publications.

STUDY SELECTION AND DATA EXTRACTION: All relevant publications were reviewed. Summarization of the PSQIA was carried out by legal textual analysis.

DATA SYNTHESIS: PL 109-41 provides privilege and confidentiality for patient safety work product (PSWP) developed for reporting to patient safety organizations (PSOs). It does not establish federal mandatory reporting of significant errors; rather, it relies on existing state reporting systems. The Act does not preempt stronger state protections for PSWP. The Agency for Healthcare Research and Quality is directed to certify PSOs and promote the establishment of a national network of patient safety databases. Whistleblower protection and penalties for unauthorized disclosure of PSWP are among its enforcement mechanisms.

CONCLUSIONS: The Act protects clinicians who report minor errors to PSOs and protects the information from disclosure, but providers must increasingly embrace a culture of interdisciplinary concern for patient safety if this protection is to have real impact on patient care.

Key Words: legislation, medication errors, patient safety, quality improvement

Published Online, April 25, 2006. www.theannals.com, DOI 10.1345/aph.1G485

THIS ARTICLE IS APPROVED FOR CONTINUING EDUCATION CREDIT
ACPE UNIVERSAL PROGRAM NUMBER: 407-000-06-009-H03


This article has been cited by other articles:


Home page
American Journal of Medical QualityHome page
J. R. Clarke, J. C. Lerner, and W. Marella
The Role for Leaders of Health Care Organizations in Patient Safety
American Journal of Medical Quality, October 1, 2007; 22(5): 311 - 318.
[Abstract] [PDF]




homecopy help contact us subscription past issues search current issue
Copyright © 2006 by Harvey Whitney Books Company.